88IV - PR Newswire Asia's news


Waters Sets Benchmark for Standardized Spectral Flow Cytometry with Commercial Launch of BD FACSDiscover A7 Cell Analyzer Enables routine 50+ parameter experiments with BD SpectralFX™ Technology, accelerating breakthrough discoveries in the fight against cancer and other diseases. Minimizes instrument and user differences ... 2026-09-14T Biotechnology Health Care/Hospital Medical Equipment Medical/Pharmaceuticals
Results from Phase III Study of Trastuzumab Botidotin versus T-DM1 in HER2-Positive Breast Cancer Published in JCO CHENGDU, China , Sept. 14, 2026 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. ("Kelun-Biotech" or "the Company", 6990.HK) announced that results from the ... 2026-09-14T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Tomonari Abe, President of Abe Yoando Pharma, Selected as First Japanese Speaker at Longevity Investors Conference 2026 in Switzerland - Head of 295-year-old Japanese Pharmaceutical Pioneer to Present Asia's Longevity Growth Strategies and Bioscientific Research Initiatives at Prestigious Conference - ... 2026-09-14T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Antengene Publishes Preclinical Research Paper on CD73 Small Molecule Inhibitor ATG-037 Combined with Selinexor in Cancer Gene Therapy SHANGHAI and HONG KONG , Sept. 14, 2026 /PRNewswire/ -- Antengene Corporation Limited ( "Antengene" , SEHK: 6996.HK) , a leading innovative, commercial-stage global biotech company dedicated ... 2026-09-14T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Accro Bioscience Announces Inclusion of AC-101 tablets in the NMPA CDE's "Caring Plan-Extension" Pilot Program for Rare Disease Drug Development NEW YORK and SUZHOU, China , Sept. 14, 2026 /PRNewswire/ -- On September 14, 2026 (China Standard Time, UTC+8), Accro Bioscience announced tha t AC-101 tablets have been included in the Rare Diseases ... 2026-09-14T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
FDA Approves Telix's Brain Cancer Imaging Drug Pixclara Pixclara® is the first FDA-approved FET-PET imaging drug for glioma (brain cancer). Approval addresses a significant unmet need, helping physicians to differentiate recurrent or progressive glioma ... 2026-09-14T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Ivonescimab Versus Pembrolizumab in First-Line PD-L1-Positive NSCLC: Positive Overall Survival Results from HARMONi-2 Presented at WCLC 2026 HONG KONG , Sept. 13, 2026 /PRNewswire/ -- Akeso, Inc. (9926.HK) today announced the presentation of positive overall survival (OS) results from the randomized, double-blind, multicenter, registrational ... 2026-09-13T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
THE GALIEN FOUNDATION ANNOUNCES INAUGURAL PRIX GALIEN JAPAN FORUM & AWARDS CEREMONY Prestigious Life Sciences Platform and Awards Launch in Tokyo to Celebrate Breakthrough Innovation ... 2026-09-11T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
ABEC Opens New Manufacturing Facility in Wilson, North Carolina Grand Opening Ceremony Scheduled for September 24, 2026 ... 2026-09-10T Biotechnology Health Care/Hospital
TenNor Therapeutics Reports Positive Phase IIa POC Data for Rifaquizinone (TNP-2092), the First Non-Surgical Therapy Candidate for Periprosthetic Joint Infection — Phase IIb multicenter trial initiated, bringing this potential life-changing therapy closer to patients — ... 2026-09-10T Biotechnology Health Care/Hospital Medical/Pharmaceuticals

PR Newswire Asia's news > Biotechnology